Catalyst Wire Dossier Catalyst Wire Dossier

Subunit trivalent nonadjuvated influenza vaccine

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subunit trivalent nonadjuvated influenza vaccine, covering 2014-01-29 to 2014-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above [Phase 2]

See pricing